Expression of miRNA-146a in nasopharyngeal carcinoma is upregulated by Epstein-Barr virus latent membrane protein 1

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1237-1242

  Zhao, Yinghai ^a   Chen, Xiaoyi ^a   Jing, Min ^b   Du, Haijun ^c   Zeng, Yi ^c  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b The First People's Hospital of Neijiang   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Epstein Barr virus; Latent membrane protein 1; miRNA 146a; Nasopharyngeal carcinoma

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 3; LATENT MEMBRANE PROTEIN 1; MICRORNA 146A; STAT PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOPHARYNGITIS; UPREGULATION; VIRUS CARCINOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL MEMBRANE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNGITIS; PROMOTER REGIONS, GENETIC; UP-REGULATION; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 84866436534     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1933     Document Type: Article

References (38)

1. Brooks L, Yao QY, Rickinson AB and Young LS: Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66: 2689-2697, 1992.
2. Thompson MP and Kurzrock R: Epstein-Barr virus and cancer. Clin Cancer Res 10: 803-821, 2004. (Pubitemid 38198878)
3. Zhang M, Zong YS, He JH, Lin SX, Zhong BL and Liang YJ: Comparison of Epstein-Barr virus infection and 30 bp-deleted LMP1 gene among four histological types of nasopharyngeal carcinoma. Chin Med J 117: 608-611, 2004. (Pubitemid 38579087)
4. Tao Q, Young LS, Woodman CB and Murray PG: Epstein-Barr virus (EBV) and its associated human cancers - genetics, epigenetics, pathobiology and novel therapeutics. Front Biosci 11: 2672-2713, 2006. (Pubitemid 43806572)
5. Zheng H, Li LL, Hu DS, Deng XY and Cao Y: Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol 4: 185-196, 2007.
6. Akiba H, Nakano H, Nishinaka S, et al: CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem 273: 13353-13358, 1998. (Pubitemid 28246911)
7. Deng L, Yang J, Zhao XR, et al: Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1. Cell Res 13: 187-194, 2003.
8. Thornburg NJ, Kulwichit W, Edwards RH, Shair KH, Bendt KM and Raab-Traub N: LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene 25: 288-297, 2006. (Pubitemid 43083690)
9. Young LS and Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768, 2004. (Pubitemid 39331148)
10. Shao JY, Huang XM, Yu XJ, et al: Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Anticancer Res 21: 3021-3029, 2001.
11. Gao J, Luo X, Tang K, Li X and Li G: Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji). J Virol Methods 136: 193-199, 2006. (Pubitemid 44051593)
12. Bandres E, Cubedo E, Agirre X, et al: Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29, 2006.
13. Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004. (Pubitemid 38327724)
14. Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771, 2005.
15. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007. (Pubitemid 46096921)
16. Wang X, Tang S, Le SY, et al: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557, 2008.
17. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS and Welch DR: Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69: 1279-1283, 2009.
18. Taganov KD, Boldin MP, Chang KJ and Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486, 2006. (Pubitemid 44267285)
19. Luo X, Yang W, Ye DQ, et al: A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 7: e1002128, 2011.
20. He H, Jazdzewski K, Li W, et al: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080, 2005. (Pubitemid 43049568)
21. Motsch N, Pfuhl T, Mrazek J, Barth S and Grasser FA: Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 4: 131-137, 2007. (Pubitemid 351237914)
22. Cameron JE, Yin Q, Fewell C, et al: Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol 82: 1946-1958, 2008. (Pubitemid 351206940)
23. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR and de la Chapelle A: Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105: 7269-7274, 2008. (Pubitemid 351754467)
24. Xu T, Zhu Y, Wei QK, et al: A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29: 2126-2131, 2008.
25. Zhang H, Luo XQ, Zhang P, et al: MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 4: e7826, 2009.
26. Couturier JP and Root-Bernstein RS: HIV may produce inhibitory microRNAs (miRNAs) that block production of CD28, CD4 and some interleukins. J Theor Biol 235: 169-184, 2005.
27. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM and Ganem D: SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435: 682-686, 2005. (Pubitemid 40825513)
28. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG and Fraser NW: Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442: 82-85, 2006. (Pubitemid 44064213)
29. Rana TM: Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 8: 23-36, 2007.
30. Chen Y and Chen XY: Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1. Ai Zheng 21: 498-503, 2002 (In Chinese).
31. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
32. Henderson A, Ripley S, Heller M and Kieff E: Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc Natl Acad Sci USA 80: 1987-1991, 1983. (Pubitemid 13079219)
33. Kieser A, Kilger E, Gires O, Ueffing M, Kolch W and Hammerschmidt W: Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J 16: 6478-6485, 1997. (Pubitemid 27483273)
34. Gires O, Kohlhuber F, Kilger E, et al: Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J 18: 3064-3073, 1999. (Pubitemid 29255615)
35. Everly DN Jr, Mainou BA and Raab-Traub N: Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol 78: 13470-13478, 2004. (Pubitemid 39612747)
36. Li HM, Zhuang ZH, Wang Q, et al: Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 23: 4488-4494, 2004. (Pubitemid 38850427)
37. Hau PM, Tsang CM, Yip YL, Huen MS and Tsao SW: Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells. PLoS One 6: e21176, 2011.
38. Talaty P, Emery A and Everly DN Jr: Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation. Virol J 8: 414, 2011.